Sangamo Therapeutics, Inc. (SGMO)
0.119
-0.01
(-10.39%)
USD |
NASDAQ |
Apr 30, 16:00
0.118
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics EPS Diluted (Quarterly) : -0.1108 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics, Inc. | -0.1944 |
| Precipio, Inc. | 0.2954 |
| INmune Bio, Inc. | -0.198 |
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.42M |
| Revenue (Quarterly) | 14.23M |
| Total Expenses (Quarterly) | 51.65M |
| Enterprise Value | 60.86M |
| Gross Profit Margin (Quarterly) | 86.77% |
| Profit Margin (Quarterly) | -263.0% |
| Earnings Yield | -371.7% |
| Normalized Earnings Yield | -348.24 |